Painful bone and soft tissue tumor
Conditions
Interventions
Following percutaneously inserting electrode(IceSeed or IceRod
Galil Medical, Yokneam, Israel), cryoablation for painful bone and soft tissue tumor is performed using CryoHit (Galil Medical)
cryoablation is performed in two cycles of maximum 15 minutes freezing and at least 2 minutes thawing.
Sponsors
Okayama University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Painful bone and soft tissue tumor with resistance of medication. 2) Pathologically confirmed painful bone and soft tissue tumor. 3) Target lesion is evaluated with imagings. 4) Life expectancy >= 1 month. 5) Written informed consent. 6) Patient's age is more than 20 years old. 7) Not a candidate for surgery or refuse surgery.
Exclusion criteria
Exclusion criteria: 1) Vital organ and/or vessel on the needle route. 2) Patient has the following comorbidities. a) Heart failure (NYHA >= III) b) Active infection except for virus hepatitis 3) Body temperature of 38 degree or more. 4) Target lesion is not able to be evaluated with imagings. 5) Pregnant. 6) Worse bone fracture caused by cryoablation. 7) Worse quality of life caused by cryoablation. 8) Inadequate cardiac, hepatic, renal, respiratory, coagulation, and bone marrow functions. 9) Not eligible determined by the responding physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of adverse events (Time Frame: 1 month post-cryoablation) | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in VAS, efficacy, and imagings 1 month after cryoablation | — |
Countries
Japan
Contacts
Public ContactToshihiro Iguchi
Okayama University Hospital Department of Radiology
Outcome results
None listed